Who is the CEO of Park Medi World Ltd?
- Answer Field
-
The MD/Chief Executive Officer of Park Medi World Limited is Dr. Sanjay Sharma.
Park Medi World Limited operates a healthcare network primarily focused on multi-super speciality hospitals in North India. The organisation runs facilities under the Park brand, offering a range of medical services across several locations. Its network consists of hospitals accredited under recognised national quality frameworks, with a presence in states such as Haryana, Delhi, Punjab, and Rajasthan. The organisation has expanded its hospital capacity over recent periods and disclosed plans for further expansion in multiple cities. Its operations include a large workforce of clinical and support staff, with facilities equipped for intensive care and surgical procedures. The business model is centred around hospital-based healthcare delivery, supported by established clinical departments across specialities.
Applications for the IPO can be made through an online or offline process based on the investor’s preferred platform. The application can be initiated using a demat account and a trading interface that supports IPO bidding. After logging in, the IPO section can be selected, and the applicant may choose the Park Medi World IPO from the list of available offerings. The required details, including quantity based on the defined lot size, can be entered along with the applicable payment option through UPI or other accepted modes. Once submitted, an approval request is received through the payment interface. After confirming the mandate, the application is registered and remains subject to the allotment process carried out as per the stated timelines in the public offering document.
For more details, visit the Park Medi World Limited IPO page.
Details | Information |
IPO Date | December 10, 2025 to December 12, 2025 |
Issue Size | 5,67,90,123 shares (aggregating up to ₹920.00 Cr) |
Price Band | ₹154 to ₹162 per share |
Lot Size | 92 shares |
Listing At | BSE, NSE |
Repayment/ prepayment, in full or in part, of outstanding borrowings availed by the Company and the Subsidiaries
Funding capital expenditure for development of new hospital by the Subsidiary Park Medicity (NCR)
Funding capital expenditure for purchase of medical equipment by the Company and the Subsidiaries, Blue Heavens and Ratangiri
Unidentified inorganic acquisitions and general corporate purposes
Event<./b> | Date |
|---|---|
IPO Open Date | Wed, Dec 10, 2025 |
IPO Close Date | Fri, Dec 12, 2025 |
Tentative Allotment | Mon, Dec 15, 2025 |
Initiation of Refunds | Tue, Dec 16, 2025 |
Credit of Shares to Demat | Tue, Dec 16, 2025 |
Tentative Listing Date | Wed, Dec 17, 2025 |
Cut-off time for UPI mandate confirmation | 5 PM on Fri, Dec 12, 2025 |
₹154 to ₹162 per share
Application | Lots | Shares | Amount |
Retail (Min) | 1 | 92 | ₹14,904 |
Retail (Max) | 13 | 1,196 | ₹1,93,752 |
S-HNI (Min) | 14 | 1,288 | ₹2,08,656 |
S-HNI (Max) | 67 | 6,164 | ₹9,98,568 |
B-HNI (Min) | 68 | 6,256 | ₹10,13,472 |
The Park Medi World Limited IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:
Access your trading account using the broker's app or website.
Go to the IPO section to view active IPO listings.
Locate Park Medi World Limited IPO in the list of available IPOs and click the ‘Apply’ button.
Specify the number of shares (lot size: 92 shares) within the price band of ₹154 to ₹162 per share.
Enter your UPI ID for payment authorisation and ensure sufficient funds in your bank account.
Review your application details and confirm the UPI mandate before 5 PM on the last application day.
Submit the application and monitor the allotment status to check if shares have been allocated to you.
Total Assets: Grew from ₹1,592.82 crore in FY23 to ₹2,320.93 crore as of Sept 2025.
Total income: Reached ₹823.39 crore in FY25 as compared to ₹1,272.18 crore in FY23.
Profit After Tax (PAT): Stood at ₹139.14 crore for Sept 2025 as compared to ₹228.19 crore in FY23.
Net Worth: Recorded at ₹1,153.05 crore in FY25 in comparison to ₹667.55 crore in FY23.
Reserves and surplus: Stood at ₹1,187.77 crore in FY25 as compared to ₹653.09 crore in FY23.
EBITDA: Stood at ₹217.14 crore in Sept 2025 in comparison to ₹390.34 crore in FY23.
The organisation has recorded a steady rise in its overall asset base over the reported periods, indicating continued investment in infrastructure and operations.
Total income has shown variation across the periods, reflecting shifts in operating performance and revenue composition.
Profit figures over the periods highlight changes in earnings, influenced by operational costs and expansion activities.
The company’s net worth has increased over time, supported by retained earnings and internal accruals.
Reserves have expanded over the reported periods, reflecting accumulation of surplus generated from business activities.
Operating performance, measured through earnings before interest, taxes, depreciation and amortisation, indicates changes that align with the organisation’s ongoing growth plans and hospital network expansion.
Expansion plans, including new facilities and equipment, may involve operational challenges, regulatory approvals, and execution-related uncertainties.
The business operates in a sector influenced by policy changes, healthcare regulations, and evolving industry standards, which may affect future performance.
The organisation has expanded its network and disclosed plans for further growth in multiple regions, supported by hospital-based healthcare delivery.
The IPO proceeds are proposed to be used for debt reduction, facility development, and medical equipment procurement, which may support the organisation’s long-term operational strategy.
KPI | Values |
ROE | 20.68% |
ROCE | 17.47% |
Debt/Equity | 0.61 |
RoNW | 20.08% |
PAT Margin | 15.30% |
EBITDA Margin | 26.71% |
Price to Book Value | 6.09 |
Registrar | Lead Manager(s) |
|---|---|
Kfin Technologies Ltd. | Nuvama Wealth Management Ltd. |
Park Medi World Ltd.
12, Meera Enclave Near Keshopur,
Bus Depot, Outer Ring Road,
New Delhi, New Delhi, 110018
Phone: + 91 124 696 000
Email: company.secretary@parkhospital.in
Website: http://www.parkhospital.in/
The details of the offering present information on the organisation’s hospital network, expansion plans, use of funds, and the proposed timelines for the issue. The business model is based on hospital-based healthcare delivery across multiple regions, with facilities operating under accredited quality frameworks. The document also outlines the application steps for interested participants using online platforms supported by a demat account.
The information shared in the public documents includes the proposed purpose of the proceeds, the price band, and the applicable dates. The allotment process follows the timelines stated in the offering schedule. Applicants can track the status through their trading platform after submitting the mandate. Further details are available in the public offer document and on the dedicated IPO information page.
Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your Park Medi World IPO allotment status.
No result found
The MD/Chief Executive Officer of Park Medi World Limited is Dr. Sanjay Sharma.
Park Medi World operates a network of multi-speciality hospitals under the “Park Hospitals” brand across North India. The company provides a broad set of medical services including diagnostics, specialised treatments, emergency care and surgeries, aiming to serve both urban and semi-urban populations. The business model is based on establishing and expanding hospital infrastructure, offering diverse medical services to a wide demographic, which may support long-term demand if it continues to maintain quality standards and manage operations effectively.
The public offering size of the IPO is approximately ₹920 crore.
Tentatively, the basis of allotment is expected to be finalized around December 15, 2025.
Based on publicly available information, the leadership and board structure of Park Medi World include individuals holding defined roles such as CEO, Managing Director, and other directors. There are no verified public disclosures indicating significant governance issues or structural red flags.
To apply, an investor must log in to their trading or broker account, navigate to the IPO section, select the Park Medi World IPO, specify the number of lots (in multiples of 92 shares), enter their UPI ID for payment authorisation, and confirm the UPI mandate before the specified deadline. Once submitted, the application is processed and is subject to allotment based on demand and availability.
Yes. A demat account is required to apply for the IPO because shares, if allotted, will be credited to the investor’s demat account for holding and trading.
After allotment is finalised (tentatively on December 15, 2025), the registrar’s website will publish the allotment status. If shares are allotted, they will be credited to your demat account (expected around December 16, 2025); you can check your demat account or use the registrar’s allotment status tool to confirm allocation.
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading